Article
Reteplase-induced Hypotension in Patients Undergoing Thrombolysis in Acute Myocardial Infarction- Case Series
2024-02-13
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction:</bold> Reteplase is the second-generation tissue plasminogen activator used as a thrombolytic agent for myocardial infarction patients. It has better tolerability as compared to streptokinase. Bleeding is one of the recorded side effects of reteplase. <bold>Case presentation:</bold> In this case, a series of 2 patients noticed an incidence of hypotension after the in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c49c69ed-ca9b-5e0c-8d0d-81189eeceff2
- DOI
- 10.21203/rs.3.rs-3896953/v1
